Progenitor Labs
Latest round
- Seed
Last raised
- Mar 2013
Total raised
- $6M
Investors
- 1
About Progenitor Labs
Founded in 2010 and headquartered in the UK, Progenitor Labs Limited focuses on advanced technology solutions for both B2B and B2C markets.Progenitor Labs Limited offers a range of innovative products designed to solve critical issues pertaining to efficiency and accessibility. Their offerings are tailored for both large enterprises seeking workflow optimization and individual consumers looking for user-friendly applications. The company is strategizing to expand its operations into new markets, specifically targeting regions in Asia and North America by 2025.
Who invested in Progenitor Labs
1 investor across 1 round
See all investors in Progenitor Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 11, 2013
Amount
$6M
Investors
Questions about Progenitor Labs
Who invested in Progenitor Labs?
Progenitor Labs has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Progenitor Labs raised?
Progenitor Labs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Progenitor Labs last raise money?
Progenitor Labs's most recent round on record is a Seed, in Mar 2013.
What does Progenitor Labs do?
Founded in 2010 and headquartered in the UK, Progenitor Labs Limited focuses on advanced technology solutions for both B2B and B2C markets.
Where is Progenitor Labs headquartered?
Progenitor Labs is headquartered in UK.
Which VCs invest in companies like Progenitor Labs?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Progenitor Labs's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Progenitor Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.